Evidence map›Paper›PMID 26543203›Full record

ArticleJournal of medical genetics2016

Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin-Siris syndrome.

Annmarie Hempel, Alistair T Pagnamenta, Moira Blyth, Sahar Mansour, Vivienne McConnell, Ikuyo Kou, Shiro Ikegawa, Yoshinori Tsurusaki, Naomichi Matsumoto, Adriana Lo-Castro and 11 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of medical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. [A case of Berry syndrome associated withZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Expanding the Spectrum of Endocrine Abnormalities Associated With SOX11-related Disorders.The Journal of clinical endocrinology and metabolism · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. SEM-2/SoxC regulates multiple aspects ofbioRxiv : the preprint server for biology · 2024
    Article
  13. Review
  14. Functional Insight into and Refinement of the Genomic Boundaries of theInternational journal of molecular sciences · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Transcription factors in microcephaly.Frontiers in neuroscience · 2023
    Review
  19. Neurodevelopmental disorder with dystonia due to SOX6 mutations.Molecular genetics & genomic medicine · 2022
    Article
  20. Episignature Mapping ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 6 countries.

Annmarie HempelInstitute for Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Alistair T PagnamentaNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Moira BlythDepartment of Clinical Genetics, Chapel Allerton Hospital, Leeds, UK.
Sahar MansourDepartment of Clinical Genetics, St George's Hospital, London, UK.
Vivienne McConnellDepartment of Genetic Medicine, Floor A, Belfast City Hospital, Belfast, UK.
Ikuyo KouLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan.
Shiro IkegawaLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan.
Yoshinori TsurusakiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Adriana Lo-CastroDepartment of Neuroscience, Pediatric Neurology Unit, Tor Vergata University of Rome, Rome, Italy.
Ghislaine PlessisService de génétique, CHU de Caen-Hôpital de la Côte de Nacre, Caen, France.
Beate AlbrechtInstitut fur Humangenetik, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.
Agatino BattagliaThe Stella Maris Clinical Research Institute for Child and Adolescent Neurology and Psychiatry, Pisa, Italy.
Jenny C TaylorNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Malcolm F HowardNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
David KeaysInstitute of Molecular Pathology, Vienna, Austria.
Aman Singh SohalPaediatric Neurology, Birmingham Children's Hospital, Birmingham, UK.
DDD Collaboration
Susanne J KühlInstitute for Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
Usha KiniDepartment of Clinical Genetics, Oxford University Hospitals NHS Trust, Oxford, UK.
Alisdair McNeillINSIGNEO Institute for in silico medicine, Sheffield University, Sheffield, UK Sheffield Institute for Translational Neuroscience, Sheffield University, Sheffield, UK Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
National Institute for Health Research · GBRIKEN Center for Integrative Medical Sciences · JPUniversität Ulm · DEYokohama City University · JPBelfast City Hospital · GBBirmingham Children's Hospital · GBCentre for Human Genetics · GBChapel Allerton Hospital · GBEssen University Hospital · DEFondazione Stella Maris · ITOxford University Hospitals NHS Trust · GBResearch Institute of Molecular Pathology · ATSt George's Hospital · GBUniversité de Caen Normandie · FRUniversity of Rome Tor Vergata · ITUniversity of Sheffield · GB

Funding

Department of HealthMedical Research Council G0900747 91070Wellcome TrustWellcome Trust 090532/Z/09/ZWellcome Trust WT098051
6 · The paper itself

Abstract

backgroundSOX11 is a transcription factor proposed to play a role in brain development. The relevance of SOX11 to human developmental disorders was suggested by a recent report of SOX11 mutations in two patients with Coffin-Siris syndrome. Here we further investigate the role of SOX11 variants in neurodevelopmental disorders.

methodsWe used array based comparative genomic hybridisation and trio exome sequencing to identify children with intellectual disability who have deletions or de novo point mutations disrupting SOX11. The pathogenicity of the SOX11 mutations was assessed using an in vitro gene expression reporter system. Loss-of-function experiments were performed in xenopus by knockdown of Sox11 expression.

resultsWe identified seven individuals with chromosome 2p25 deletions involving SOX11. Trio exome sequencing identified three de novo SOX11 variants, two missense (p.K50N; p.P120H) and one nonsense (p.C29*). The biological consequences of the missense mutations were assessed using an in vitro gene expression system. These individuals had microcephaly, developmental delay and shared dysmorphic features compatible with mild Coffin-Siris syndrome. To further investigate the function of SOX11, we knocked down the orthologous gene in xenopus. Morphants had significant reduction in head size compared with controls. This suggests that SOX11 loss of function can be associated with microcephaly.

conclusionsWe thus propose that SOX11 deletion or mutation can present with a Coffin-Siris phenotype.

Indexed as

Sequence DeletionAbnormalities, MultipleAdolescentAdultAnimalsChildChild, PreschoolFaceFemaleGene Knockdown TechniquesHand Deformities, CongenitalHumansIntellectual DisabilityMaleMicrocephalyMicrognathismSOX11 protein, humanSOXC Transcription FactorsClinical geneticsCopy-numberDevelopmentalDiagnostics tests

Identifiers

PMID26543203
PMCPMC4789813
OpenAlexW2177646230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.